簡介

本頁面提供了有關 Colin John Meyer 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Colin John Meyer已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:RETA / Reata Pharmaceuticals Inc - Class A Chief Innovation Officer 0
如何解讀這些圖表

以下圖表顯示了在Colin John Meyer進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Colin John Meyer 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2023-09-26 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -81,633 0 -100.00
2023-08-17 2023-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -596 81,633 -0.72 168.74 -100,569 13,774,761
2023-08-17 2023-08-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -2,144 82,229 -2.54 169.07 -362,483 13,902,350
2023-07-10 2023-07-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
A - Award 6,000 84,373 7.66
2023-05-17 2023-05-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -625 78,373 -0.79 80.94 -50,590 6,343,824
2023-05-17 2023-05-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -1,139 78,998 -1.42 85.77 -97,695 6,775,880
2023-05-17 2023-05-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -4,469 80,137 -5.28 84.76 -378,778 6,792,156
2023-03-08 2023-03-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -621 84,606 -0.73 84.57 -52,518 7,155,129
2023-03-06 2023-03-03 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -5,286 85,227 -5.84 87.35 -461,732 7,444,578
2023-03-06 2023-03-02 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -810 90,513 -0.89 90.58 -73,370 8,198,668
2023-03-06 2023-03-02 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -11,181 91,323 -10.91 88.50 -989,518 8,082,086
2023-03-06 2023-03-02 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -19,099 102,504 -15.71 87.55 -1,672,117 8,974,225
2023-03-06 2023-03-02 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -34,794 121,603 -22.25 86.49 -3,009,333 10,517,443
2023-03-06 2023-03-02 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -22,752 156,397 -12.70 85.23 -1,939,153 13,329,716
2023-03-06 2023-03-02 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 88,636 179,149 97.93
2023-03-01 2023-02-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
A - Award 15,000 90,513 19.86
2023-01-04 2023-01-03 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
A - Award 23,513 75,513 45.22
2022-01-05 2022-01-03 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 70,000 70,000
2022-01-05 2022-01-03 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
A - Award 35,000 52,000 205.88
2021-06-16 2021-06-16 4 RETA REATA PHARMACEUTICALS INC
Class B common Stock
M - Exercise 19,525 74,304 35.64 11.62 226,880 863,412
2021-06-16 2021-06-16 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -19,525 0 -100.00
2021-06-16 2021-06-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -500 17,000 -2.86 145.92 -72,960 2,480,635
2021-06-16 2021-06-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -1,217 17,500 -6.50 145.11 -176,598 2,539,406
2021-06-16 2021-06-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -2,483 18,717 -11.71 143.98 -357,507 2,694,907
2021-06-16 2021-06-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -8,867 21,200 -29.49 142.83 -1,266,502 3,028,064
2021-06-16 2021-06-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -12,518 30,067 -29.40 142.08 -1,778,510 4,271,805
2021-06-16 2021-06-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -6,494 42,585 -13.23 141.09 -916,253 6,008,416
2021-06-16 2021-06-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -4,107 49,079 -7.72 139.98 -574,889 6,869,975
2021-06-16 2021-06-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -3,814 53,186 -6.69 139.14 -530,662 7,400,055
2021-06-16 2021-06-14 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -5,000 54,779 -8.36
2021-06-16 2021-06-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -400 57,000 -0.70 146.15 -58,460 8,330,550
2021-06-16 2021-06-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -2,760 57,400 -4.59 145.49 -401,540 8,350,873
2021-06-16 2021-06-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -4,225 60,160 -6.56 144.44 -610,273 8,689,715
2021-06-16 2021-06-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -12,615 64,385 -16.38 143.54 -1,810,751 9,241,791
2021-06-16 2021-06-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 5,000 77,000 6.94
2021-01-06 2021-01-04 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 24,000 24,000
2020-11-18 2020-11-17 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -6,395 59,779 -9.66
2020-11-18 2020-11-17 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
M - Exercise 6,395 66,174 10.70 11.00 70,345 727,914
2020-11-18 2020-11-17 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -6,395 88,636 -6.73
2020-11-18 2020-11-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -200 72,000 -0.28 170.59 -34,118 12,282,480
2020-11-18 2020-11-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -1,930 72,200 -2.60 166.14 -320,643 11,995,048
2020-11-18 2020-11-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -1,815 74,130 -2.39 165.25 -299,922 12,249,708
2020-11-18 2020-11-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -2,450 75,945 -3.13 164.44 -402,888 12,488,692
2020-11-18 2020-11-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 6,395 78,395 8.88
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -18,605 59,779 -23.74
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
M - Exercise 18,605 78,384 31.12 11.00 204,655 862,224
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -18,605 95,031 -16.37
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -100 72,000 -0.14 175.00 -17,500 12,600,000
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -200 72,100 -0.28 174.98 -34,996 12,616,058
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -100 72,300 -0.14 173.75 -17,375 12,562,125
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -2,207 72,400 -2.96 172.61 -380,943 12,496,711
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -3,824 74,607 -4.88 171.38 -655,367 12,786,342
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale -12,174 78,431 -13.44 170.48 -2,075,397 13,370,744
2020-11-18 2020-11-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 18,605 90,605 25.84
2020-11-10 2020-11-09 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
S - Sale X -25,000 72,000 -25.77 175.00 -4,375,000 12,600,000
2020-01-06 2020-01-02 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 25,000 25,000
2019-12-17 2019-12-16 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -69,828 59,779 -53.88
2019-12-17 2019-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 69,828 97,000 256.99
2019-11-12 2019-11-11 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 17,750 17,750
2019-11-12 2019-10-14 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 17,750 17,750
2019-01-29 2019-01-28 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
M - Exercise 622 129,607 0.48 8.11 5,044 1,051,113
2019-01-29 2019-01-28 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -622 0 -100.00
2019-01-03 2019-01-02 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 35,500 35,500
2017-12-13 2017-12-12 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -11,822 19,525 -37.71
2017-12-13 2017-12-12 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -827 622 -57.07
2017-12-13 2017-12-12 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2,351 0 -100.00
2017-12-13 2017-12-12 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
M - Exercise 11,822 128,985 10.09 11.62 137,372 1,498,806
2017-12-13 2017-12-12 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
M - Exercise 827 117,163 0.71 8.11 6,707 950,192
2017-12-13 2017-12-12 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
M - Exercise 2,351 116,336 2.06 7.86 18,479 914,401
2017-12-07 2017-12-06 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 87,700 87,700
2016-12-08 2016-12-07 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 90,000 90,000
2016-08-17 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 7,000 27,172 34.70 16.26 113,820 441,817
2016-06-02 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -10,172 113,985 -8.19
2016-06-02 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 10,000 20,172 98.31 11.00 110,000 221,892
2016-06-02 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 10,172 10,172
2016-05-26 2016-05-25 4 RETA REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 113,636 113,636
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)